ALS Treatment: What’s FDA-Approved â and What Actually Helps
ð§ Understanding ALS: Where Treatment Stands Right Now
Amyotrophic lateral sclerosis progressively affects the nerve cells controlling voluntary muscle movement. Here’s an accurate, current look at approved treatments and what supportive care actually involves.
ðĨ This article is for general education and is not medical advice. ALS treatment decisions should always be made with a neurologist familiar with your specific case.
ð FDA-Approved ALS Medications
Riluzole (brand names Rilutek, and newer forms Tiglutik and Exservan for people with swallowing difficulty) has been the standard of care for over two decades. It works by reducing glutamate, a chemical that can damage motor neurons when it builds up. Clinical studies show it extends survival by roughly two to three months on average â it doesn’t reverse damage or restore strength.
Edaravone (Radicava, available as an IV infusion or an oral suspension called Radicava ORS) can slow the rate of functional decline, as measured on standard ALS rating scales. Its effect on long-term survival hasn’t been firmly established.
Qalsody (tofersen) is a newer, genetically targeted therapy approved in 2023 specifically for ALS caused by a mutation in the SOD1 gene â a rare form representing a small share of ALS cases. It’s given by spinal injection and requires genetic testing to confirm eligibility; it is not expected to help ALS that isn’t SOD1-related.
â ïļ A drug called Relyvrio (AMX0035) was previously available but was withdrawn from the US market after a Phase 3 trial failed to confirm meaningful benefit. If you or a loved one was prescribed Relyvrio in the past, this is worth discussing with your neurologist.
𧎠Genetic Testing Now Plays a Bigger Role
Because tofersen only helps people with a specific SOD1 mutation, genetic testing has become a more routine part of ALS care than it was a decade ago â it helps identify who may be a candidate for targeted therapy and can also inform family members about hereditary risk.
This is a conversation to have directly with a neurologist or genetic counselor, since testing carries implications beyond the immediate treatment decision.
ðĪ Managing Symptoms and Daily Function
Beyond disease-modifying drugs, day-to-day quality of life is shaped heavily by supportive care: physical and occupational therapy to maintain function longer, speech therapy as swallowing and speech are affected, respiratory support (including non-invasive ventilation) as breathing muscles weaken, and mobility equipment â power wheelchairs, hospital beds, and communication devices â introduced proactively rather than only after a crisis.
Nuedexta is a separate FDA-approved medication used specifically for pseudobulbar affect â sudden, uncontrollable episodes of crying or laughing that occur in some ALS patients â not for the underlying disease itself.
Multidisciplinary ALS clinics, typically affiliated with major medical centers, coordinate neurology, respiratory, nutrition, and equipment needs in one place and are associated with better outcomes in research studies.
Frequently Asked Questions
Is there a cure for ALS?
No. Current FDA-approved treatments modestly slow progression or, in the specific case of SOD1-ALS, target the genetic cause â but none reverses existing nerve damage or stops the disease entirely.
What is the life expectancy after an ALS diagnosis?
Survival varies widely by individual, but typical survival is often cited as two to five years from symptom onset, with a meaningful percentage of people living longer, especially with early multidisciplinary care and respiratory support.
Should every ALS patient get genetic testing?
It’s worth discussing with a neurologist. Testing is most directly useful for identifying candidates for tofersen (SOD1-ALS) and for informing family members of hereditary risk, but the decision to test is personal and should include genetic counseling.
What equipment does EasyMed help with for ALS patients?
As mobility and strength decline, many families need power wheelchairs, hospital beds, patient lifts, and communication aids â often introduced in stages as needs change. Our diagnostic and repair guidance can help keep existing equipment running reliably during a period when downtime is especially hard.